Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2766]

Less intensive chemo avoids irreversible side effects in children's cancer

Less intensive chemo avoids irreversible side effects in children's cancer

Second-line cetuximab active beyond progression in quadruple wild-type patients with metastatic colorectal cancer

Second-line cetuximab active beyond progression in quadruple wild-type patients with metastatic colorectal cancer

ESMO GI: Internal radiation therapy increases progression free survival for liver mets in colorectal cancer patients

ESMO GI: Internal radiation therapy increases progression free survival for liver mets in colorectal cancer...

Second-line cetuximab active beyond progression in quadruple wild-type patients with mCRC

Second-line cetuximab active beyond progression in quadruple wild-type patients with mCRC

SENRI trial opens window to evaluate NK1 antagonists for emesis prevention in oxaliplatin chemotherapy

SENRI trial opens window to evaluate NK1 antagonists for emesis prevention in oxaliplatin chemotherapy

A blood test for early detection of breast cancer metastasis

A blood test for early detection of breast cancer metastasis

Josep Tabernero to head ESMO

Josep Tabernero to head ESMO

Stress hormones could undermine breast cancer therapy

Stress hormones could undermine breast cancer therapy

Multimodality treatment for metastatic lung cancer that includes surgery may improve survival rates

Multimodality treatment for metastatic lung cancer that includes surgery may improve survival rates

“Boosted” radiation dose may make some pancreatic cancers resectable

“Boosted” radiation dose may make some pancreatic cancers resectable

More from ecancer